Table 4-3 Treatment 3.

a. Total
	EVT				Vascular prosthesis					Vein usage				Vein quality
	Aorta/iliac	Femoral/popliteal	Tibioperoneal/foot	Others	Polyester	ePTFE	Vein	Others	(−)	In-situ	Non-reversed	Reversed	Spliced	Good	Poor
Rutherford 4	39	53	37	5	8	36	71	6	13	13	22	31	7	64	7
Rutherford 5	85	176	197	5	32	81	246	2	24	53	68	104	26	211	35
Rutherford 6	24	26	35	2	4	10	66	1	12	13	29	24	3	61	5
Total	148	255	269	12	44	127	383	9	49	79	119	159	36	336	47
b. ASO
	EVT				Vascular prosthesis					Vein usage				Vein quality
	Aorta/iliac	Femoral/popliteal	Tibioperoneal/foot	Others	Polyester	ePTFE	Vein	Others	(−)	In-situ	Non-reversed	Reversed	Spliced	Good	Poor
Rutherford 4	39	53	36	5	8	36	67	6	13	11	22	29	7	60	7
Rutherford 5	84	176	193	5	32	78	238	2	23	52	64	100	26	204	34
Rutherford 6	24	26	35	2	4	10	64	1	12	13	28	23	3	59	5
Total	147	255	264	12	44	124	369	9	48	76	114	152	36	323	46

ePTFE: expanded polytetrafluoroethylene, EVT: endovascular treatment